Speaker(s): 

Melissa (Missie) Kelly, MS, LCGC- co-director of the MyCode Genomic Screening and Counseling Program, Genomic Data Scientist Lead, Geisinger (Has nothing to disclose) 

Juliann (Jules) Savatt, MS, LCGC- co-director of the MyCode Genomic Screening and Counseling Program, Assistant Professor, Geisinger (Has nothing to disclose) 

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

• Describe the MyCode GSC process for evaluating genes appropriate for return
• Recognize phenotypic presentation of genes recently added to the MyCode GSC gene list
• Summarize clinical management for genes recently added to the MyCode GSC gene list

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Adam Buchanan, MS, MPH, LCGC, Juliann Savatt, MS, LCGC, Melissa Kelly, MS, LCGC, Marc Williams, MD, and Cara McCormick, MPH have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPAA compliant. 

Commercial Support for this Session

None